For the year ending 2025-12-31, HCAT made $311,136K in revenue. -$177,974K in net income. Net profit margin of -57.20%.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Revenue | 311,136 | |||
| Technology | 69,741 | |||
| Professional Services | 89,720 | |||
| Total cost of revenue, excluding depreciation and amortization | 159,461 | |||
| Sales and marketing | 52,477 | |||
| Research and development | 49,770 | |||
| General and administrative | 49,559 | |||
| Depreciation and amortization | 50,500 | |||
| Impairment of goodwill and intangible assets | 110,223 | |||
| Total operating expenses | 312,529 | |||
| Loss from operations | -160,854 | |||
| Interest and other (expense) income, net | -16,404 | |||
| Loss before income taxes | -177,258 | |||
| Income tax provision | 716 | |||
| Net loss | -177,974 | |||
| Basic EPS | -2.55 | |||
| Diluted EPS | -2.55 | |||
| Basic Average Shares | 69,896,000 | |||
| Diluted Average Shares | 69,896,000 | |||
Health Catalyst, Inc. (HCAT)
Health Catalyst, Inc. (HCAT)